Media headlines about PerkinElmer (NYSE:PKI) have been trending somewhat positive on Wednesday, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. PerkinElmer earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the medical research company an impact score of 47.5310831760224 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the news headlines that may have effected Accern Sentiment Analysis’s analysis:
Shares of PerkinElmer (NYSE:PKI) traded up $0.55 during trading on Wednesday, reaching $74.77. 98,952 shares of the company’s stock were exchanged, compared to its average volume of 742,752. The company has a market capitalization of $8,211.78, a P/E ratio of 28.11, a PEG ratio of 1.72 and a beta of 0.76. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.27 and a quick ratio of 0.90. PerkinElmer has a fifty-two week low of $53.97 and a fifty-two week high of $84.49.
PerkinElmer (NYSE:PKI) last announced its earnings results on Thursday, January 25th. The medical research company reported $0.97 EPS for the quarter, topping the Zacks’ consensus estimate of $0.94 by $0.03. PerkinElmer had a net margin of 12.97% and a return on equity of 13.30%. The business had revenue of $641.63 million during the quarter, compared to the consensus estimate of $619.14 million. During the same period in the previous year, the company posted $0.83 earnings per share. The firm’s revenue was up 13.2% on a year-over-year basis. equities research analysts predict that PerkinElmer will post 3.52 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Stockholders of record on Friday, April 13th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 12th. This represents a $0.28 annualized dividend and a dividend yield of 0.37%. PerkinElmer’s dividend payout ratio (DPR) is currently 10.61%.
A number of research firms recently weighed in on PKI. Robert W. Baird reaffirmed a “buy” rating and issued a $88.00 price objective on shares of PerkinElmer in a research note on Friday, January 26th. Barclays upped their price objective on shares of PerkinElmer from $69.00 to $73.00 and gave the stock an “underweight” rating in a research note on Friday, January 26th. Cowen reaffirmed a “hold” rating and issued a $84.00 price objective on shares of PerkinElmer in a research note on Friday, January 26th. Zacks Investment Research upgraded shares of PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 target price for the company in a report on Monday, January 8th. Finally, Evercore ISI initiated coverage on shares of PerkinElmer in a report on Wednesday, January 3rd. They issued an “in-line” rating and a $77.00 target price for the company. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $76.85.
In other news, Director Alexis P. Michas sold 5,000 shares of the company’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $73.18, for a total transaction of $365,900.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Frank Anders Wilson sold 37,535 shares of the company’s stock in a transaction dated Thursday, December 7th. The shares were sold at an average price of $70.14, for a total transaction of $2,632,704.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 59,812 shares of company stock worth $4,263,863. Corporate insiders own 2.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/14/perkinelmer-pki-earning-somewhat-favorable-media-coverage-accern-reports.html.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.